FDA NDC Directory · JSON-LD · Markdown

Oxybutynin Chloride

NDC 65162-372 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerAmneal Pharmaceuticals LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA204010
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsOXYBUTYNIN CHLORIDE (10 mg/1)
Marketing started20151102
Package count4

External sources

Source: openFDA. Public-domain (CC0).